US Medicaid Program Will Hit Swiss Wallets Hard, Roche CEO Says

Benzinga_recent_news12-22 21:43

Deals between pharmaceutical companies and the U.S. government to reduce drug prices are likely to drive higher costs for new medicines in Switzerland over time, according to Thomas Schinecker, CEO of...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment